Valvular & structural heart disease

Phenotyping patients with a low-flow, low-gradient aortic stenosis and a preserved ejection fraction undergoing transcatheter aortic valve implantation

ESC Heart FailPublished unsupervised echocardiographic clustering

Authors' conclusion

One-third of TAVI patients with LF-LG aortic stenosis have an typical HFpEF/AF phenotype and a poor prognosis. They may benefit from guideline-directed HFpEF therapy, including SGLT-2 inhibitors and MRA.

Study context

Population
Patients with low flow, low-gradient (LF-LG) aortic stenosis and preserved ejection fraction undergoing transcatheter aortic valve implantation (TAVI) (UMCG, the Netherlands)patients undergoing TAVI, 216/628 patients with complete data had LF-LG preserved ejection fraction (pEF) · internal validation 405 · external validation (TUMunich, Germany) 173
Participants
827 patients
Comparison
Cluster 1 versus cluster 2
  • Cluster 1n = 77
  • Cluster 2n = 139
Outcome
LF-LG pEF prevalence
Methodological detailsPrincipal component analysis, K-means clustering, internal and external validation
  • Principal component analysis
  • K-means clustering
  • Internal and external validation

Performance

As reported in the abstract

Patients with complete data who had LF-LG pEF

216 of 628

34%

Mean age

78.8 (± 7.19) years

Female

57.9%

Further findings

OutcomeCluster 1
Echocardiographic and clinical features
H2FPEF score ≥649.4%
HFA-pEFF score ≥571.4%

Echocardiographic and clinical features

Cluster 1: larger left and right atrial dimensions, impaired left ventricular global longitudinal strain, reduced left atrial reservoir strain; older, higher rates of atrial fibrillation (AF) and heart failure (HF) versus cluster 2

Cardiovascular mortality and HF-hospitalization · 1- and 5-year

Cluster 1 had higher risk, comparable to that of classical LF-LG patients
  • Validation reproduced these results

Original publication

Phenotyping patients with a low-flow, low-gradient aortic stenosis and a preserved ejection fraction undergoing transcatheter aortic valve implantation. ESC Heart Fail. Published 31 May 2026. doi:10.1093/eschf/xvag146

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.